Cita APA

Tanaka, N., Asakawa, I., Fujimoto, K., Anai, S., Hirayama, A., Hasegawa, M., . . . Hirao, Y. (2012). Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer. BioMed Central.

Chicago Style Citation

Tanaka, Nobumichi, Isao Asakawa, Kiyohide Fujimoto, Satoshi Anai, Akihide Hirayama, Masatoshi Hasegawa, Noboru Konishi, i Yoshihiko Hirao. Minimal Percentage of Dose Received By 90% of the Urethra (%UD90) Is the Most Significant Predictor of PSA Bounce in Patients Who Underwent Low-dose-rate Brachytherapy (LDR-brachytherapy) for Prostate Cancer. BioMed Central, 2012.

Cita MLA

Tanaka, Nobumichi, et al. Minimal Percentage of Dose Received By 90% of the Urethra (%UD90) Is the Most Significant Predictor of PSA Bounce in Patients Who Underwent Low-dose-rate Brachytherapy (LDR-brachytherapy) for Prostate Cancer. BioMed Central, 2012.